These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions. Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CD56 immunohistochemistry in thyroid lesions. Pyo JS; Kim DH; Yang J Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356 [TBL] [Abstract][Full Text] [Related]
6. [Thyroid pathology. Case n(o) 2: Follicular oncocytic adenoma]. Guyétant S Ann Pathol; 2015 Oct; 35(5):395-401. PubMed ID: 26387604 [No Abstract] [Full Text] [Related]
7. Oncocytic Change in Thyroid Pathology. Asa SL; Mete O Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422 [TBL] [Abstract][Full Text] [Related]
8. Differential diagnostic significance of HBME-1, CK19 and S100 in various thyroid lesions. Palo S; Biligi DS Malays J Pathol; 2017 Apr; 39(1):55-67. PubMed ID: 28413206 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260 [TBL] [Abstract][Full Text] [Related]
10. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma. Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595 [TBL] [Abstract][Full Text] [Related]
11. Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. Straccia P; Santeusanio G; Pierconti F; Brunelli C; Fadda G Appl Immunohistochem Mol Morphol; 2019; 27(10):726-731. PubMed ID: 30358610 [TBL] [Abstract][Full Text] [Related]
12. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852 [TBL] [Abstract][Full Text] [Related]
13. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Mete O; Asa SL Endocr Pathol; 2010 Mar; 21(1):16-24. PubMed ID: 20013317 [TBL] [Abstract][Full Text] [Related]
14. Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings. Song SJ; LiVolsi VA; Montone K; Baloch Z Cytopathology; 2017 Dec; 28(6):488-494. PubMed ID: 29165886 [TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of new biomarkers and application in thyroid cytology. Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437 [TBL] [Abstract][Full Text] [Related]
16. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases. Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280 [TBL] [Abstract][Full Text] [Related]
17. Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Mai KT; Elmontaser G; Perkins DG; Thomas J; Stinson WA Int J Surg Pathol; 2005 Jan; 13(1):37-41. PubMed ID: 15735853 [TBL] [Abstract][Full Text] [Related]
18. Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Rago T; Di Coscio G; Basolo F; Scutari M; Elisei R; Berti P; Miccoli P; Romani R; Faviana P; Pinchera A; Vitti P Clin Endocrinol (Oxf); 2007 Jan; 66(1):13-20. PubMed ID: 17201796 [TBL] [Abstract][Full Text] [Related]
19. A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma. Sponziello M; Silvestri G; Verrienti A; Perna A; Rosignolo F; Brunelli C; Pecce V; Rossi ED; Lombardi CP; Durante C; Filetti S; Fadda G Endocrine; 2018 Nov; 62(2):492-495. PubMed ID: 29700698 [No Abstract] [Full Text] [Related]
20. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015. Glomski K; Nosé V; Faquin WC; Sadow PM Endocr Pathol; 2017 Jun; 28(2):177-185. PubMed ID: 28444500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]